Clinical Trial Update: A Study of TAK-226 for Transfusion-Dependent Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TAK-226 for transfusion-dependent anemia in Japanese patients with lower-risk myelodysplastic syndromes is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• TAK-226

Snippet

Sponsor: Takeda | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: NOT_YET_RECRUITING